TGA Approval

IRINOTECAN EPSL irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial (439212)

ARTG ID

439212

ARTG Name

IRINOTECAN EPSL irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial

Sponsor

Eugia Pharma (Australia) Pty Ltd

ARTG Date

March 17, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

EUGIA PHARMA (AUSTRALIA) PTY LTD

Ingredient Name

irinotecan hydrochloride trihydrate

Empowering clinical research with data-driven insights and AI-powered tools.

IRINOTECAN EPSL irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial (439212) - TGA 批准文号 | MedPath